Gastric Cancer Gc clinical trials

Explore recruiting gastric cancer gc clinical trials.

Recruiting gastric cancer gc studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Gastric Cancer Gc trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Local and systemic immune modulation by Rilvegostomig (AZD2936) in the treatment of advanced gastric cancer (RILVE Project)

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 3, Multicenter, 2-Arm Randomized, Open-Label Study of Trastuzumab Deruxtecan in Subjects with HER2 Positive Metastatic and/or Unresectable Gastric or Gastro Esophageal Junction (GEJ) Adenocarcinoma Subjects who have Progressed on or After a Trastuzumab-Containing Regimen (DESTINY-Gastric04)

Hungary, Portugal, Germany, Spain, Romania, Belgium +4 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Phase II Study of Avelumab plus chemotherapy in the peri-operative treatment for patients with resectable Gastric cancer (GC) or Gastroesophageal Junction cancer (GEJC). Moneo trial

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 1/2, Open-label Study of Nivolumab Monotherapy or Nivolumab combined with Ipilimumab in Subjects with Advanced or Metastatic Solid Tumors

Germany

Phase I and Phase II (Integrated)- Other EU CTIS Study details

A Phase 2 Study of [68Ga]BED003 for PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications

Netherlands, Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

GRACIE : Phase II study evaluating ivonescimab in combination with chemotherapy for first- and second-line treatment of advanced or metastatic gastric and gastroesophageal adenocarcinoma patients

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Gastric Cancer Gc trials by city

Gastric Cancer Gc in Toronto Gastric Cancer Gc in Vancouver Gastric Cancer Gc in Montreal Gastric Cancer Gc in Calgary Gastric Cancer Gc in Edmonton Gastric Cancer Gc in Ottawa Gastric Cancer Gc in Winnipeg Gastric Cancer Gc in Quebec City Gastric Cancer Gc in Hamilton Gastric Cancer Gc in Kitchener Gastric Cancer Gc in London Gastric Cancer Gc in Halifax Gastric Cancer Gc in New York Gastric Cancer Gc in Los Angeles Gastric Cancer Gc in Chicago Gastric Cancer Gc in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease